Machatha Stephen Insider Trades

Insider Trading History

Track insider trading activity for Machatha Stephen. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
Chief Development Officer
Holding Value $390k 221,799 shares
Last Trade
Aug 11, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$114k 22,073 shares
$5.15
$1.76
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
Chief Development Officer
Holding Value $356k 202,427 shares
Last Trade
Mar 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.25M 202,427 shares
$6.17
$1.76
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
Chief Development Officer
Holding Value $417k 236,771 shares
Last Trade
Aug 12, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$76k 16,041 shares
$4.74
$1.76
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
Chief Development Officer
Holding Value $445k 252,812 shares
Last Trade
Mar 12, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$36.5k 11,537 shares
$3.16
$1.76
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
Chief Development Officer
Holding Value $429k 243,495 shares
Last Trade
Mar 12, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$36.5k 11,537 shares
$3.16
$1.76
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
Chief Development Officer
Holding Value $449k 255,032 shares
Last Trade
Mar 11, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$62.2k 18,231 shares
$3.41
$1.76
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
Chief Development Officer
Holding Value $714k 405,450 shares
Last Trade
Mar 09, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.47M 405,450 shares
$3.62
$1.76
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
Chief Development Officer
Holding Value $388k 220,258 shares
Last Trade
Feb 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.49M 220,258 shares
$6.76
$1.76
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
Chief Development Officer
Holding Value $481k 273,263 shares
Last Trade
Jul 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$876k 185,605 shares
$4.72
$1.76
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
Chief Development Officer
Holding Value $440k 250,000 shares
Last Trade
Mar 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.13M 250,000 shares
$4.52
$1.76
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
Chief Development Officer
Holding Value $205k 116,201 shares
Last Trade
Apr 12, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.36M 116,201 shares
$11.71
$1.76
Aldeyra Therapeutics
Aldeyra Therapeutics ALDX
Chief Development Officer
Holding Value $35.4k 20,091 shares
Last Trade
Dec 08, 2020 Sale
$1.98M 273,333 shares
$7.26
$1.76

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up